Sentinel Lymph Node Working Group Data Acquisition Project
The goal is to use the collected data to determine outcomes, identify patterns of recurrence, and identify patient or tumor related factors that influence outcome or recurrence. This will allow for a better understanding of the natural history of the diseases studied and will provide information for better therapies and follow-up schedules.
Any patient who is treated at the University of Texas Southwestern Medical Center with Stage I or II malignant melanoma, Merkel cell carcinoma, localized squamous cell carcinoma, breast cancer or other skin malignancy who undergoes or has undergone a selective sentinel lymph node dissection procedure as part of the standard of care. Pregnant women and minors may be included in this study as it is of minimal risk provided consent can be obtained.